WEST PHARMACEUTICAL SERVICES INC
WSTAPI behind this page
WST Q3 2025 request
Playground key active
/api/financials?ticker=WST&year=2025&quarter=3
Pick an endpoint and run the request.Income Statement
| Metric | Q3 2025 | Q3 2024 | YoY |
|---|---|---|---|
| Revenue | 804.6 | 746.9 | +7.7% |
Show Business Segments breakouts |
|||
| Contract-Manufactured Products | 157.1 | 145.5 | +8.0% |
| Contract-Manufactured Products · Operating Segments | 157.1 | 145.5 | +8.0% |
| Proprietary Products | 647.5 | 601.4 | +7.7% |
| Proprietary Products · Operating Segments | 647.5 | 601.4 | +7.7% |
Show Equity Components breakouts |
|||
| Accumulated Gain Loss Net Cash Flow Hedge Parent · Foreign Exchange Contract | -0.4 | — | — |
Show Consolidation Items breakouts |
|||
| Operating Segments | 804.6 | 746.9 | +7.7% |
Show Related Party Transactions By Related Party breakouts |
|||
| Affiliated Entity | 3.4 | 3.5 | -2.9% |
| Cost of Revenue | 510.3 | 482.2 | +5.8% |
Show Business Segments breakouts |
|||
| Contract-Manufactured Products · Operating Segments | 126.8 | 116.5 | +8.8% |
| Proprietary Products · Operating Segments | 383.5 | 365.7 | +4.9% |
Show Equity Components breakouts |
|||
| Accumulated Gain Loss Net Cash Flow Hedge Parent · Foreign Exchange Contract | -0.5 | 0.7 | -171.4% |
| Gross Profit | 294.3 | 264.7 | +11.2% |
| Research & Development | 17.1 | 15.5 | +10.3% |
Show Business Segments breakouts |
|||
| Proprietary Products · Operating Segments | 17.1 | 15.5 | +10.3% |
| Selling, General & Administrative | 102.7 | 83.5 | +23.0% |
Show Business Segments breakouts |
|||
| Contract-Manufactured Products · Operating Segments | 7.5 | 6.7 | +11.9% |
| Proprietary Products · Operating Segments | 65.6 | 56.6 | +15.9% |
| Other Income Expense | 6.9 | 4.4 | +56.8% |
| Operating Income | 167.6 | 161.3 | +3.9% |
Show Business Segments breakouts |
|||
| Contract-Manufactured Products · Operating Segments | 22.3 | 21.8 | +2.3% |
| Proprietary Products · Operating Segments | 175.2 | 158.2 | +10.7% |
Show Consolidation Items breakouts |
|||
| Operating Segments | 197.5 | 180 | +9.7% |
| Interest Expense | 0.2 | 0.7 | -71.4% |
| Investment Income Net | -4.7 | -4.6 | -2.2% |
| Other Non-Operating Income (Expense) | 0.2 | 0.7 | -71.4% |
| Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments | 171.9 | 164.5 | +4.5% |
Show Equity Components breakouts |
|||
| Accumulated Defined Benefit Plans Adjustment · Reclassification Out Of Accumulated Other Comprehensive Income | 0.2 | 0.3 | -33.3% |
| Accumulated Gain Loss Net Cash Flow Hedge Parent · Reclassification Out Of Accumulated Other Comprehensive Income | 0.1 | -0.7 | +114.3% |
| Income Tax Expense (Benefit) | 34 | 32.4 | +4.9% |
| Income Loss From Equity Method Investments | -2.1 | -3.9 | +46.2% |
| Net Income | 140 | 136 | +2.9% |
Show Equity Components breakouts |
|||
| Accumulated Defined Benefit Plans Adjustment · Reclassification Out Of Accumulated Other Comprehensive Income | 0.2 | 0.2 | 0.0% |
| Accumulated Gain Loss Net Cash Flow Hedge Parent · Reclassification Out Of Accumulated Other Comprehensive Income | 0.1 | -0.5 | +120.0% |
| Retained Earnings | 140 | 136 | +2.9% |
Show Reclassification Out Of Accumulated Other Comprehensive Income breakouts |
|||
| Reclassification Out Of Accumulated Other Comprehensive Income | 0.3 | -0.3 | +200.0% |
| EPS (Basic) | 1.94 | 1.87 | +3.7% |
| EPS (Diluted) | 1.92 | 1.85 | +3.8% |
| Wtd Avg Shares (Basic) | 72.2 | 72.8 | -0.8% |
| Wtd Avg Shares (Diluted) | 72.6 | 73.4 | -1.1% |
| General & Administrative (Q) | — | — | — |
Show Consolidation Items breakouts |
|||
| Corporate And Reconciling Items | -19 | -14.3 | -32.9% |
| Income Before Taxes | 171.9 | 164.5 | +4.5% |
| Comprehensive Income | 126.4 | 216.6 | -41.6% |
| Other Comprehensive Income | -13.6 | 80.6 | -116.9% |
Show Equity Components breakouts |
|||
| Accumulated Other Comprehensive Income | -13.6 | 80.6 | -116.9% |
| Foreign Currency Transaction Gain Loss Before Tax | 2.7 | 4.1 | -34.1% |
Balance Sheet
| Metric | Q3 2025 | Q3 2024 | YoY |
|---|---|---|---|
| Current Assets | |||
| Cash & Cash Equivalents | 628.5 | 490.9 | +28.0% |
| Accounts Receivable | 625 | 524.3 | +19.2% |
| Inventory | 438 | 401.2 | +9.2% |
| Other Assets Current | 131.8 | 134.2 | -1.8% |
Show Related Party Transactions By Related Party breakouts |
|||
| Affiliated Entity | 1.2 | 2.7 | -55.6% |
| Total Current Assets | 1,823.3 | 1,550.6 | +17.6% |
| Non-Current Assets | |||
| Property, Plant & Equipment | 1,740.6 | 1,571 | +10.8% |
| Operating Lease Right-of-Use Assets | 97.8 | 108 | -9.4% |
| Goodwill | 110.6 | 108.8 | +1.7% |
| Deferred Tax Assets | 27.9 | 37.6 | -25.8% |
| Other Non-Current Assets | 75.8 | 69.3 | +9.4% |
| Total Assets | 4,105.8 | — | — |
Show Business Segments breakouts |
|||
| Contract-Manufactured Products · Operating Segments | 685.9 | — | — |
| Proprietary Products · Operating Segments | 2,989.3 | — | — |
Show Consolidation Items breakouts |
|||
| Corporate And Reconciling Items | 430.6 | — | — |
| Other Assets | |||
| Property Plant And Equipment Gross | 3,232.9 | 2,990.7 | +8.1% |
| Accumulated Depreciation Depletion And Amortization Property Plant And Equipment | 1,492.3 | 1,419.7 | +5.1% |
| Investments In Affiliates Subsidiaries Associates And Joint Ventures | 220.9 | 217.5 | +1.6% |
| Intangible Assets Net Excluding Goodwill | 8.9 | 12.3 | -27.6% |
| Current Liabilities | |||
| Accounts Payable | 255.8 | 224.3 | +14.0% |
| Accrued Salaries Wages And Benefits Current | 111.8 | 79.6 | +40.5% |
| Accrued Income Taxes Current | 33.3 | 33.4 | -0.3% |
| Operating Lease Liability Current | 21.4 | 19.9 | +7.5% |
| Other Liabilities Current | 213.1 | 159.3 | +33.8% |
Show Related Party Transactions By Related Party breakouts |
|||
| Affiliated Entity | 19.8 | 24.8 | -20.2% |
| Total Current Liabilities | 635.4 | 516.5 | +23.0% |
| Non-Current Liabilities | |||
| Long-Term Debt | 202.7 | 202.6 | 0.0% |
| Deferred Tax Liabilities | 22.8 | 9.4 | +142.6% |
| Pension And Other Postretirement Defined Benefit Plans Liabilities Noncurrent | 31.1 | 30.2 | +3.0% |
| Operating Lease Liabilities | 73.5 | 82.3 | -10.7% |
| Deferred Compensation Liability Classified Noncurrent | 13.5 | 15.2 | -11.2% |
| Other Non-Current Liabilities | 75.3 | 66.8 | +12.7% |
| Total Liabilities | 1,054.3 | 923 | +14.2% |
| Long-Term Debt | 202.7 | 202.6 | 0.0% |
| Stockholders' Equity | |||
| Common Stock | 18.8 | 18.8 | 0.0% |
| Retained Earnings | 4,262.4 | 3,856.9 | +10.5% |
| Accumulated Other Comprehensive Income | -102.3 | -136.3 | +24.9% |
| Treasury Stock Common Value | -1,127.4 | -1,010.6 | -11.6% |
| Total Stockholders' Equity | 3,051.5 | 2,752.1 | +10.9% |
Show Equity Components breakouts |
|||
| Accumulated Defined Benefit Plans Adjustment | -10.8 | -11.3 | +4.4% |
| Accumulated Gain Loss Net Cash Flow Hedge Parent | 0.9 | 2 | -55.0% |
| Accumulated Other Comprehensive Income | -102.3 | -136.3 | +24.9% |
| Accumulated Translation Adjustment | -95 | -129.3 | +26.5% |
| Aoci Equity Method Investment Parent | 2.6 | 2.3 | +13.0% |
| Common Stock | 18.8 | 18.8 | 0.0% |
| Retained Earnings | 4,262.4 | 3,856.9 | +10.5% |
| Treasury Stock Common | -1,127.4 | -1,010.6 | -11.6% |
| Total Liabilities & Equity | 4,105.8 | 3,675.1 | +11.7% |
Cash Flow Statement
| Metric | YTD Q3 2025 | YTD Q3 2024 | YoY |
|---|---|---|---|
| Operating Activities | |||
| Depreciation | 122.2 | 112 | +9.1% |
| Adjustment For Amortization | 2.2 | 2.7 | -18.5% |
| Stock-Based Compensation | 17.1 | 14.4 | +18.8% |
Show Consolidation Items breakouts |
|||
| Corporate And Reconciling Items | 17.1 | 14.4 | +18.8% |
| Restructuring Charges | 2.5 | -2.5 | +200.0% |
Show Consolidation Items breakouts |
|||
| Corporate And Reconciling Items | 21.9 | -0.9 | +2533.3% |
| Corporate And Reconciling Items · Other Income (Expense) | 17.5 | -2.5 | +800.0% |
| Corporate And Reconciling Items · Selling General And Administrative Expenses | 4.4 | 1.6 | +175.0% |
| Asset Impairment Charges | 4.4 | 1.9 | +131.6% |
| Other Non-Cash Items | -4.4 | -9.7 | +54.6% |
| Increase Decrease In Operating Capital | -1.9 | -20.6 | +90.8% |
| Net Cash from Operations | 503.7 | 463.3 | +8.7% |
| Depreciation & Amortization | 124.4 | 114.7 | +8.5% |
Show Business Segments breakouts |
|||
| Contract-Manufactured Products · Operating Segments | 20.3 | 15.1 | +34.4% |
| Proprietary Products · Operating Segments | 101.5 | 96.8 | +4.9% |
Show Consolidation Items breakouts |
|||
| Corporate And Reconciling Items | 2.6 | 2.8 | -7.1% |
| Change in Deferred Revenue | 5.9 | 0.1 | +5800.0% |
| Investing Activities | |||
| Capital Expenditures | -209.8 | -272.1 | +22.9% |
| Net Cash from Investing | -209.8 | -273.9 | +23.4% |
| Financing Activities | |||
| Finance Lease Principal Payments | -0.8 | -23.2 | +96.6% |
| Payments For Excise Tax | -4.2 | — | — |
| Payments Of Dividends Common Stock | -45.4 | -43.8 | -3.7% |
| Proceeds From Stock Options Exercised | 8.2 | 24 | -65.8% |
| Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans | 5.4 | 5.6 | -3.6% |
| Share Repurchases | -134 | -506.5 | +73.5% |
| Tax Withholding for Share Compensation | -2.6 | -5.5 | +52.7% |
| Net Cash from Financing | -173.4 | -553.7 | +68.7% |
| Supplemental | |||
| Unpaid Capital Expenditures | 38.1 | 50.3 | -24.3% |
| Other Cash Flow | |||
| Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | 23.4 | 1.3 | +1700.0% |
| Net Change in Cash | 143.9 | -363 | +139.6% |
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | 628.5 | 490.9 | +28.0% |
Values in millions USD. Source: SEC EDGAR 10-Q filing.